Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GELESIS HOLDINGS, INC. | Chief Medical Officer | Common Stock | 314K | May 6, 2022 | Direct | ||
GELESIS HOLDINGS, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 270K | May 6, 2022 | Direct | ||
Organicell Regenerative Medicine, Inc. | Chief Executive Officer, Director | Common Stock | 0 | $1.32 | Dec 19, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCEL | Organicell Regenerative Medicine, Inc. | Dec 19, 2023 | 1 | -$6.9K | 4 | Dec 20, 2023 | Chief Executive Officer, Director |
OCEL | Organicell Regenerative Medicine, Inc. | Jun 28, 2023 | 2 | $10.4K | 4/A | Dec 21, 2023 | Chief Executive Officer, Director |
OCEL | Organicell Regenerative Medicine, Inc. | Jun 28, 2023 | 2 | $59.4K | 4 | Jun 30, 2023 | Chief Executive Officer, Director |
OCEL | Organicell Regenerative Medicine, Inc. | Jun 6, 2023 | 0 | $0 | 3 | Jun 9, 2023 | CEO and Director, Director |
GLSH | GELESIS HOLDINGS, INC. | May 6, 2022 | 4 | $0 | 4 | May 9, 2022 | Chief Medical Officer |
GLSH | GELESIS HOLDINGS, INC. | Jan 13, 2022 | 0 | $0 | 3 | Jan 24, 2022 | Chief Medical Officer |